- Applied Genetic Technologies intends to sell 3.57M shares at a price of $13-15 in its Nasdaq IPO.
- At $14, Applied Genetic would raise a net $44.8M.
- The company, which develops gene therapy for inherited retinal disease, plans to trade under the ticker symbol "AGTC."
- There's also a greenshoe option of 535,650 shares. (S-1)
- ETF: IPO
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs